About IRRAS
IRRAS is a company based in Stockholm (Sweden) founded in 2012 was acquired by ClearPoint Neuro in November 2025.. IRRAS has raised $11.25 million across 2 funding rounds from investors including ClearPoint Neuro, Serendipity Innovations and Invest Stockholm. IRRAS offers products and services including IRRA flow, Hummingbird Quad, Hummingbird Solo, and Hummingbird ICP Control Module. IRRAS operates in a competitive market with competitors including CereVasc, Tissuemed, Longeviti, Aqueduct Critical Care and NeuroDx, among others.
- Headquarter Stockholm, Sweden
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Irras Ab
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.25 M (USD)
in 2 rounds
-
Latest Funding Round
$11.25 M (USD), Series A
May 11, 2016
-
Investors
ClearPoint Neuro
& 2 more
-
Employee Count
Employee Count
-
Acquired by
ClearPoint Neuro
(Nov 06, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IRRAS
IRRAS offers a comprehensive portfolio of products and services, including IRRA flow, Hummingbird Quad, Hummingbird Solo, and Hummingbird ICP Control Module. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides automated irrigation and continuous pressure monitoring for drainage.
Offers quad ICP monitoring with drainage for advanced neuromonitoring.
Delivers solo ICP monitoring with accurate parenchymal measurements.
Enables rezeroing and multimodal monitoring through a single access point.
Unlock access to complete
Unlock access to complete
Funding Insights of IRRAS
IRRAS has successfully raised a total of $11.25M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $11.25 million completed in May 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $11.2M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2016 | Amount | Series A - IRRAS | Valuation | Serendipity Innovations |
|
| Mar, 2013 | Amount | Seed - IRRAS | Valuation | Invest Stockholm |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in IRRAS
IRRAS has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include ClearPoint Neuro, Serendipity Innovations and Invest Stockholm. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Promotes investment, business setup, and talent recruitment in Stockholm region.
|
Founded Year | Domain | Location | |
|
Software and hardware solutions for MRI-guided surgical planning are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by IRRAS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - IRRAS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Irras Comparisons
Competitors of IRRAS
IRRAS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CereVasc, Tissuemed, Longeviti, Aqueduct Critical Care and NeuroDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
eShunt device is developed for communicating hydrocephalus treatment.
|
|
| domain | founded_year | HQ Location |
Bioadhesive films are developed to seal leaks in surgical procedures.
|
|
| domain | founded_year | HQ Location |
Implantable neurosurgical devices are developed for cranial defect correction.
|
|
| domain | founded_year | HQ Location |
Novel products to manage Cerebral Spinal Fluid (CSF) pressure
|
|
| domain | founded_year | HQ Location |
Medical devices for assessing shunt function in hydrocephalus patient.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Irras
Frequently Asked Questions about IRRAS
When was IRRAS founded?
IRRAS was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is IRRAS located?
IRRAS is headquartered in Stockholm, Sweden.
Who is the current CEO of IRRAS?
Will Martin is the current CEO of IRRAS.
Is IRRAS a funded company?
IRRAS is a funded company, having raised a total of $11.25M across 2 funding rounds to date.
What does IRRAS do?
IRRAS develops devices for fluid control and management for several brain pathologies, CNS therapeutic applications, and procedures. Its products include instruments and catheters for the clinical, monitoring and surgical applications for brain pathology indications. Its flagship products IRRAflow provides, dynamic control of brain fluids, for irrigation and aspiration, precise infusion of fluids and intracranial pressure monitoring. It can be used for the treatments for infections and malignant tumors such as Ventriculitis, Meningitis, Abscesses and Osteomyelitis of the skull, and others.
Who are the top competitors of IRRAS?
IRRAS's top competitors include CereVasc, Tissuemed and Aqueduct Critical Care.
What products or services does IRRAS offer?
IRRAS offers IRRA flow, Hummingbird Quad, Hummingbird Solo, and Hummingbird ICP Control Module.
Who are IRRAS's investors?
IRRAS has 3 investors. Key investors include ClearPoint Neuro, Serendipity Innovations, and Invest Stockholm.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.